CellNetix Labs, LLC – Trademark Portfolio

Entity Type: 16

CellNetix Labs, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include LABDOX, SYMGENE, YOUR PARTNER IN PATHOLOGY, and THE ART AND SCIENCE OF PATHOLOGY. The owner is based in Seattle, WA.

Suite 200

1124 Columbia Street

Seattle, WA 98104

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CellNetix Labs, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (6 filings)

Scientific and technological services; industrial analysis and research services

44
Medical Services (4 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does CellNetix Labs, LLC have?

CellNetix Labs, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 cancelled.

What trademark classes does CellNetix Labs, LLC file in?

CellNetix Labs, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.

What are CellNetix Labs, LLC's most well-known trademarks?

CellNetix Labs, LLC's registered trademark portfolio includes well-known marks such as LABDOX, SYMGENE, YOUR PARTNER IN PATHOLOGY, and THE ART AND SCIENCE OF PATHOLOGY. These are among 4 currently registered trademarks in the portfolio.

What is CellNetix Labs, LLC's trademark registration success rate?

CellNetix Labs, LLC has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.